Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SWS Hemodialysis Care CoSHSE:688410 -0.37%88 ROC (Joel Greenblatt) % is 67.06% as of Mar. 2026, which is 571% above its 10-year median of 9.99. GuruFocus rates SHSE:688410 with a GF Score™ of 88/100 and a GF Value™ of ¥15.72 (Significantly Undervalued). The stock has 1 warning sign investors should review. Among 837 Medical Devices & Instruments companies, SWS Hemodialysis Care Co ranks better than 90.92% on this metric.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. SWS Hemodialysis Care Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 67.06%.
The historical rank and industry rank for SWS Hemodialysis Care Co's ROC (Joel Greenblatt) % or its related term are showing as below:
SHSE:688410'
s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -20.81 Med: 9.99 Max: 114.66
Current: 59.95
During the past 12 years, SWS Hemodialysis Care Co's highest ROC (Joel Greenblatt) % was 114.66%. The lowest was -20.81%. And the median was 9.99%.
SHSE:688410's ROC (Joel Greenblatt) % is ranked better than 90.92% of 837
companies
in the Medical Devices & Instruments industry
Industry Median: 5.37
vs SHSE:688410: 59.95
SWS Hemodialysis Care Co's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was 45.60% per year.
SWS Hemodialysis Care Co (SHSE:688410) ROC (Joel Greenblatt) % Explanation
The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.
SWS Hemodialysis Care Co ROC (Joel Greenblatt) % Related Terms
SWS Hemodialysis Care Co ROC (Joel Greenblatt) % Historical Data
* Premium members only.
The historical data trend for SWS Hemodialysis Care Co's ROC (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SWS Hemodialysis Care Co ROC (Joel Greenblatt) % Chart
SHSE:688410 vs ISRG, BDX, MDLN: ROC (Joel Greenblatt) % Comparison
For the Medical Instruments & Supplies subindustry, SWS Hemodialysis Care Co's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SWS Hemodialysis Care Co ROC (Joel Greenblatt) % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, SWS Hemodialysis Care Co's ROC (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where SWS Hemodialysis Care Co's ROC (Joel Greenblatt) % falls into.
SWS Hemodialysis Care Co ROC (Joel Greenblatt) % Calculation
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:
EBIT stands for Earnings Before Interest and Taxes.
Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.
GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.
Note:
The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROC (Joel Greenblatt) % of 67.06% mean?
SWS Hemodialysis Care Co (SHSE:688410) has a ROC (Joel Greenblatt) % of 67.06% as of Mar. 2026. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on SWS Hemodialysis Care Co and its competitors. This is 571% above median its historical median of 9.99. According to the industry distribution chart, SWS Hemodialysis Care Co ranks #76 out of 837 companies in the Medical Devices & Instruments industry, placing it in the top 9.1%.
Is SWS Hemodialysis Care Co's ROC (Joel Greenblatt) % too high?
SWS Hemodialysis Care Co's current ROC (Joel Greenblatt) % of 67.06% is 571% above median its 10-year median of 9.99. The Medical Devices & Instruments industry median ROC (Joel Greenblatt) % is 5.37. SWS Hemodialysis Care Co's value of 67.06% is 1148.8% above this industry median. Based on the distribution chart, SWS Hemodialysis Care Co ranks #76 out of 837 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, SWS Hemodialysis Care Co has a GF Score™ of 88/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does SWS Hemodialysis Care Co's ROC (Joel Greenblatt) % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, SWS Hemodialysis Care Co ranks #76 out of 837 companies for ROC (Joel Greenblatt) %. This places SWS Hemodialysis Care Co in the top 9% of its industry — outperforming the majority of peers. The industry median ROC (Joel Greenblatt) % is 5.37. SWS Hemodialysis Care Co's value of 67.06% is 1148.8% above this benchmark. While the company's 10-year median is 9.99 vs. the industry median of 5.37, SWS Hemodialysis Care Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Medical Devices & Instruments company?
The median ROC (Joel Greenblatt) % among Medical Devices & Instruments companies is 5.37, based on 837 companies in the industry. Companies in the top quartile (top 25%) have a ROC (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. SWS Hemodialysis Care Co's current ROC (Joel Greenblatt) % of 67.06% is 1148.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on SWS Hemodialysis Care Co and its competitors. For the Medical Devices & Instruments industry, the median ROC (Joel Greenblatt) % is 5.37 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SWS Hemodialysis Care Co's current ROC (Joel Greenblatt) % is 67.06%, which is 571% above median its own 10-year median of 9.99. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SWS Hemodialysis Care Co stock overvalued right now?
Based on GuruFocus' analysis, SWS Hemodialysis Care Co (SHSE:688410) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥15.72, compared to a current price of ¥10.87 — trading 30.9% below its estimated fair value. The current ROC (Joel Greenblatt) % is 67.06%, which is 571% above median its 10-year median of 9.99 and 1148.8% above the Medical Devices & Instruments industry median of 5.37. SWS Hemodialysis Care Co's overall GF Score™ is 88/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For SWS Hemodialysis Care Co (SHSE:688410), the current ROC (Joel Greenblatt) % is 67.06% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is SWS Hemodialysis Care Co (SHSE:688410) Overvalued in 2026?
Based on GuruFocus' analysis, SWS Hemodialysis Care Co stock appears to be undervalued.
The current stock price of ¥10.87 is trading 30.9% below its estimated GF Value™ of ¥15.72.
GuruFocus considers SWS Hemodialysis Care Co to be Significantly Undervalued.
Key valuation signals for SHSE:688410:
ROC (Joel Greenblatt) %: 67.06% (571% above median its 10-year median of 9.99)
GF Value™: ¥15.72 vs. price of ¥10.87 (30.9% below fair value)
Industry Position: 1148.8% above the Medical Devices & Instruments median (#76 of 837)
No single metric tells the full story. See the SHSE:688410 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
SWS Hemodialysis Care Co Ltd along with its subsidiaries is engaged in the field of blood purification. Its focused on patients welfare and ensuring the delivery of safe and effective products and services. The group operates through four segments: Blood Purification Equipment, Blood Purification Consumables, advanced Hemodialysis Management System, and Chain Dialysis centers. The organization is delivering medical solutions for patients with chronic kidney disease (CKD). Its products include Blood Purification Equipment Dialysis, Disposables Dialysis Center, Intelligent Management System, and Chain Dialysis centers. SWS is committed to enhancing patient wellness by prioritizing care through advanced integrated blood purification technologies.
88GF Score
Get the complete analysis for SHSE:688410
ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688410 has been successfully added to your 
